BAVA: bullish 3 drives18 % Upside potential with little risk since earnings are coming out on friday
0.70 USD
214.05 M USD
1.02 B USD
About BAVARIAN NORDIC A/S
Sector
CEO
Paul Chaplin
Headquarters
Hellerup
Website
Founded
1992
FIGI
BBG004MKB1Q9
Bavarian Nordic A/S engages in the business of developing, manufacturing, and commercializing cancer immunotherapies and vaccines for infectious diseases. The firm is involved in cancer immunotherapy including cancer pipeline, which focuses on therapeutic vaccines for breast, lung, ovarian, and prostate cancer. The company was founded on July 1, 1992 and is headquartered in Hellerup, Denmark.
BAVARIAN NORDIC - 1000% pumpI expect a very strong increase in this company’s stock due to the impending monkeypox problem. Therefore, it is a very good idea to buy it. Wishing everyone health and prosperity.
Bavarian Nordic : new mpox problemwe seem to be on the edge of a new pandemic with a deadlier mpox strain than 2022 (3-5 % mortality rate). BAVA is one of the vaccine producers and most likely got an Invitation for EUL from WHO (see www.who.int) . BAVA is one of the 2 Producers of vaccines (JYNNEOS from BAVA and ACCAM2000 from Eme
critical point herelet us se what happens here. The company has finansed it's pipelines and have also good thing in pipeline beside the selling of its vaccines.
Monkey Pox vaxBeen tracking cdc data on monkey pox from 1st week of may this year. Cases have gone from 7 to 22k+ today. Their can be much speculation as to why or what this actually will be, but that would be another website. Bavarian Nordic has already received the green light from US and EU to mass produce the
BAVA: Monkey Pox Pharma Inverse on Bullish NewsThis accompany has just opened a contract with US and EU markets for 800k dose for Monkey POX in the US. Inverse printing. When Moderna received a contract for COIVD is 4x'd. I cant see why this wouldn't at least pump another 40% to the 1.618
Monkeypox Vaccine about to break year downtrend?Now in 30 countries and just found in India UK ordering directly from the company and earnings at the end of August
Pandemic 2.0This is not financial advice and any information that you take and act upon is at your sole discretion.
History doesn't repeat itself, but if often rhymes. If the saying holds true then Bavarian Nordic (BAVA) stands to see a great increase in it's stock price.
Listen to the video for a rundown o
$BVNRY PTs 300-400 and higher Bavarian Nordic is the only company with an FDA approved Monkey Pox Vaccine
Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.